{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:16Z","timestamp":1791319816812,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112919","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:19:01Z","timestamp":1790687941000},"page":"112919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Functional interplay between LSD1 and HDAC6 supports malignant phenotypes in breast cancer models and is associated with notch-related protein changes"],"prefix":"10.1016","volume":"149","author":[{"given":"Guo","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganbiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongneng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2026.112919_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112919_bb0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112919_bb0015","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112919_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jama.2023.25881","article-title":"Analysis of breast cancer mortality in the US-1975 to 2019","volume":"331","author":"Caswell-Jin","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112919_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112919_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112919_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914964","article-title":"Epigenetic modulators as therapeutic agents in cancer","volume":"24","author":"Patnaik","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112919_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15154005","article-title":"Emerging role of epigenetic modifiers in breast cancer pathogenesis and therapeutic response","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112919_bb0055","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051803","article-title":"The interplay between DNA and histone methylation: molecular mechanisms and disease implications","volume":"22","author":"Li","year":"2021","journal-title":"EMBO Rep."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112919_bb0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112919_bb0065","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/14728222.2023.2288277","article-title":"Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study","volume":"27","author":"Johnson","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-019-0811-9","article-title":"LSD1\/KDM1A inhibitors in clinical trials: advances and prospects","volume":"12","author":"Fang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112919_bb0075","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2217\/epi-2017-0022","article-title":"A comprehensive review of lysine-specific demethylase 1 and its roles in cancer","volume":"9","author":"Hosseini","year":"2017","journal-title":"Epigenomics"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112919_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121821","article-title":"LSD1\/KDM1A, a gate-keeper of cancer stemness and a promising therapeutic target","volume":"11","author":"Karakaidos","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellsig.2026.112919_bb0085","article-title":"A state-of-the-art review on LSD1 and its inhibitors in breast cancer: molecular mechanisms and therapeutic significance","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112919_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101585","article-title":"The histone demethylase LSD1\/KDM1A mediates chemoresistance in breast cancer via regulation of a stem cell program","volume":"11","author":"Verigos","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellsig.2026.112919_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1120911","article-title":"LSD1 inhibitors for cancer treatment: focus on multi-target agents and compounds in clinical trials","volume":"14","author":"Noce","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112919_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jmcb\/mjy021","article-title":"LSD1 coordinates with the SIN3A\/HDAC complex and maintains sensitivity to chemotherapy in breast cancer","volume":"10","author":"Yang","year":"2018","journal-title":"J. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112919_bb0105","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/carcin\/bgt033","article-title":"Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells","volume":"34","author":"Vasilatos","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/onc.2016.186","article-title":"Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression","volume":"36","author":"Cao","year":"2017","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112919_bb0115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112919_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031274","article-title":"Regulation of HDAC6 catalytic activity in cancer: the role of post-translational modifications and protein-protein interactions","volume":"26","author":"Asaad","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112919_bb0125","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/0008-5472.CAN-13-3563","article-title":"\u0391-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration","volume":"75","author":"Boggs","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-020-06033-2","article-title":"HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells","volume":"186","author":"Oba","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112919_bb0140","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-19-3738","article-title":"HDAC6 plays a noncanonical role in the regulation of antitumor immune responses, dissemination, and invasiveness of breast cancer","volume":"80","author":"Banik","year":"2020","journal-title":"Cancer Res."},{"issue":"Pt C","key":"10.1016\/j.cellsig.2026.112919_bb0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.semcdb.2022.09.009","article-title":"Immunomodulatory properties of HDAC6 inhibitors in cancer diseases: new chances for sophisticated drug design and treatment optimization","volume":"154","author":"Biersack","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112919_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1277076","article-title":"Metastasis and cancer associated fibroblasts: taking it up a NOTCH","volume":"11","author":"Ghosh","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2026.112919_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.692173","article-title":"Notch signalling in breast development and cancer","volume":"9","author":"Edwards","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-10383-z","article-title":"Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer","volume":"22","author":"Yousefi","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2026.112919_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2415489","article-title":"The notch pathway in breast cancer progression","volume":"2018","author":"Kontomanolis","year":"2018","journal-title":"Sci. World J."},{"key":"10.1016\/j.cellsig.2026.112919_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00518","article-title":"Moving breast cancer therapy up a notch","volume":"8","author":"Mollen","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112919_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01649","article-title":"Notch signaling as a regulator of the tumor immune response: to target or not to target?","volume":"9","author":"Janghorban","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112919_bb0185","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc3035","article-title":"Notch signalling in solid tumours: a little bit of everything but not all the time","volume":"11","author":"Ranganathan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010094","article-title":"Context matters: NOTCH signatures and pathway in cancer progression and metastasis","volume":"10","author":"Misiorek","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112919_bb0195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cell.2009.05.050","article-title":"LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"issue":"7057","key":"10.1016\/j.cellsig.2026.112919_bb0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature04021","article-title":"An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation","volume":"437","author":"Lee","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112919_bb0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.molcel.2005.08.027","article-title":"Regulation of LSD1 histone demethylase activity by its associated factors","volume":"19","author":"Shi","year":"2005","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17913-x","article-title":"LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer","volume":"8","author":"Boulding","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112919_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/0008-5472.CAN-12-1739","article-title":"Inhibiting interactions of lysine demethylase LSD1 with snail\/slug blocks cancer cell invasion","volume":"73","author":"Ferrari-Amorotti","year":"2013","journal-title":"Cancer Res."},{"issue":"35","key":"10.1016\/j.cellsig.2026.112919_bb0220","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1038\/onc.2010.234","article-title":"Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition","volume":"29","author":"Lin","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112919_bb0225","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-05-3054","article-title":"Aberrant activation of notch signaling in human breast cancer","volume":"66","author":"Stylianou","year":"2006","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112919_bb0230","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1158\/0008-5472.CAN-05-1069","article-title":"High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival","volume":"65","author":"Reedijk","year":"2005","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112919_bb0235","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2011.04.020","article-title":"A SIRT1-LSD1 corepressor complex regulates notch target gene expression and development","volume":"42","author":"Mulligan","year":"2011","journal-title":"Mol. Cell"},{"issue":"7346","key":"10.1016\/j.cellsig.2026.112919_bb0240","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature09917","article-title":"Acetylation-dependent regulation of endothelial notch signalling by the SIRT1 deacetylase","volume":"473","author":"Guarani","year":"2011","journal-title":"Nature"},{"issue":"3\u20134","key":"10.1016\/j.cellsig.2026.112919_bb0245","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbrc.2011.11.030","article-title":"Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1","volume":"416","author":"Popko-Scibor","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2026.112919_bb0250","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112919_bb0255","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/nm.2454","article-title":"Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes","volume":"17","author":"DeRose","year":"2011","journal-title":"Nat. Med."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:53:42Z","timestamp":1791316422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826005784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":51,"alternative-id":["S0898656826005784"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112919","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional interplay between LSD1 and HDAC6 supports malignant phenotypes in breast cancer models and is associated with notch-related protein changes","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112919"}}